Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by harposon Jun 25, 2017 4:56pm

266 Views

Post# 26402955

Truly amazing DD Bencro

I have to admit that when I first heard Dr. Frost discussed, I was hoping for a larger company but I now believe that to be shortsighted. Also, if we ended up with some OPKO stock in the process that would not only diversify us but give us a chance to really participate more as this PDT tech progresses. OPKO stock is undervalued in relation to the potential of its parts.
for instance, if Merck bought us with a partial stock deal, the company is so large that it would possibly be difficult to feel the full effect of the PDT grow out.

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?